On June 14, 2024, Julie Andrews, Director at RxSight Inc (NASDAQ:RXST), executed a sale of 15,625 shares of the company at a price of $58 per share.
This cataract lens stock has gained 44% this year and over 200% since 2023. Analysts expect the company to turn profitable in 2024.
Five stocks that have been losing money are on the IBD 50 growth list because of strong sales growth. Most stocks do not have a base on their chart though.